Orion Corporation, Orion Pharma
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Finland
- Registered address
- Tengstrominkatu 8, Turku, FI-20360, Finland (FIN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003743938 · DUNS 537940319
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-04-25
- VAIDrug Quality Assurance2022-03-10
- VAIDrug Quality Assurance2019-09-06
- NAIDrug Quality Assurance2016-11-03
- NAIDrug Quality Assurance2014-06-19
- VAIDrug Quality Assurance2013-05-24
- VAIDrug Quality Assurance2010-09-03
- NAIDrug Quality Assurance2009-09-16
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- darolutamideBayer HealthCare Pharmaceuticals Inc.
- Methotrexate Sodiumin shortageSun Pharmaceutical Industries, Inc.
- toremifene citrateKyowa Kirin, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.